1. Aberg, M., Nilsson, I.M., Vilhardt, H. The release of fibrinolytic activator and factor VIII after injection of DDAVP. p. 92–97. In: Progress in Chemical Fibrinolysis and Thrombolysis, Vol.4, Eds.: Davidson, Cepezak, Samama, Desnoyers, Churchill Livingstone, 1979, Edimburgh/London/New York.
2. Aoki, N., Moroi, M., Sakada, Y., Yoshida, N., & Matsuda, M.1978, Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J. Clin. Invest., 61: 1186–1195.
3. Astrup, T. Blood coagulation, fibrinolysis and the development of the thrombogenic theory of arteriosclerosis. In: Le role de la paroi artérielle dans 1’athérogénèse. 1976. Centre. Nat. Rech. Sc.
4. Astrup, T., & Rosa, A.T. 1974. A plasminogen proactivator-activator system in human blood effective in absence of Hageman factor. Ihromb. Res. 4: 609–613.
5. Bagge, L., Carlin, G., Hjelmstedt, A., Hogstorp Jacobsson, H., Modig, J., Saldeen, T. 1979. Fibrinolysis inhibition after a standardized trauma, total hip replacement surgery. Thromb. Haemost. 42: 278 (abstract).